Carsten H. Meyer

Zitiert von

	Alle	Seit 2019
Zitate	9643	2766
h-index	54	30
i10-index	185	83

680

340

170

510

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202448 124 152 184 372 370 418 481 497 524 666 608 517 601 558 506 508 483 622 521 488 137

Öffentlicher Zugriff

Alle anzeigen

4 Artikel

1 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Eduardo B. RodriguesDepartment of Ophthalmology, Universidade Federal de Sao PauloBestätigte E-Mail-Adresse bei visumretina.com.br
Michel Eid FarahProfessor Associado do Depto de Oftalmologia da UNIFESP - EPM / Universidade Federal de São PauloBestätigte E-Mail-Adresse bei pq.cnpq.br
Frank HolzDepartment of Ophthalmology; University of Bonn; GermanyBestätigte E-Mail-Adresse bei ukbonn.de
Mauricio MaiaUniversidade Federal de São PauloBestätigte E-Mail-Adresse bei unifesp.br
Tim U. KrohneDept. of Ophthalmology, Univ. of Cologne, GermanyBestätigte E-Mail-Adresse bei uk-koeln.de
Zengping LiuDept. of Ophthalmology, National University of SingaporeBestätigte E-Mail-Adresse bei nus.edu.sg
Priv.-Doz. Dr. med. Boris Stanzel, FEBOKnappschaft Eye Clinic Sulzbach/ SaarBestätigte E-Mail-Adresse bei kksaar.de
Gustavo Barreto de MeloAffiliate Professor at the Federal University of São Paulo/ Editor-in-Chief, Int J Retina VitreousBestätigte E-Mail-Adresse bei hosergipe.com.br
Gabriel Costa de AndradePos-Doc Candidate - Department of Ophthalmology - Federal University of São Paulo / School ofBestätigte E-Mail-Adresse bei retina.com.br
Hendrik Peter Nicolas SchollDirector of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and Professor and Chairman of the Department of Ophthalmology, University of Basel, SwitzerlandBestätigte E-Mail-Adresse bei iob.ch
Peter Charbel IssaOxford Eye Hosptial, University of OxfordBestätigte E-Mail-Adresse bei oxon.org
Monika FleckensteinProfessor der MedizinBestätigte E-Mail-Adresse bei ukb.uni-bonn.de
Steffen Schmitz-ValckenbergUniversity of UtahBestätigte E-Mail-Adresse bei hsc.utah.edu
Acácio Alves de Souza Lima FilhoDepartamento de Oftalmologia e Ciências Visuais da Universidade Federal de São Paulo-UNIFESP/EPMBestätigte E-Mail-Adresse bei unifesp.br
Timothy Y Y LaiThe Chinese University of Hong KongBestätigte E-Mail-Adresse bei cuhk.edu.hk
Ana Luisa Hofling-LimaHead Professor of Ophthalmology - Departamento de Oftalmologia - EPM/UNIFESPBestätigte E-Mail-Adresse bei unifesp.br
Kai JanuschowskiMount St. Peter Eye Clinic Trier, University eye hospital TuebingeBestätigte E-Mail-Adresse bei med.uni-tuebingen.de
Rick SpaideVitreous, Retina, Macula Consultants of New YorkBestätigte E-Mail-Adresse bei vrmny.net
Focke ZiemssenUniversity LeipzigBestätigte E-Mail-Adresse bei medizin.uni-leipzig.de
Siegfried PriglingerBestätigte E-Mail-Adresse bei med.uni-muenchen.de

Folgen

Carsten H. Meyer

Professor of Ophthalmology MD, FEBO, FMH Augenzentrum Grischun Chur, Philipps-Universität Marburg

Bestätigte E-Mail-Adresse bei augenzentrum-grischun.ch - Startseite

vitreo-retinal disease - Retinal Pharmacotherapy


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans TU Krohne, N Eter, FG Holz, CH Meyer American journal of ophthalmology 146 (4), 508-512, 2008	448	2008
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans TU Krohne, Z Liu, FG Holz, CH Meyer American journal of ophthalmology 154 (4), 682-686. e2, 2012	266	2012
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration CK Chan, CH Meyer, JG Gross, P Abraham, ASD Nuthi, GT Kokame, ... Retina 27 (5), 541-551, 2007	204	2007
The use of vital dyes in ocular surgery EB Rodrigues, EF Costa, FM Penha, GB Melo, J Bottós, E Dib, B Furlani, ... Survey of ophthalmology 54 (5), 576-617, 2009	200	2009
Dynamic mechanical properties of human lenses HA Weeber, G Eckert, F Soergel, CH Meyer, W Pechhold, ... Experimental eye research 80 (3), 425-434, 2005	190	2005
Clinical use and research applications of Heidelberg retinal angiography and spectral‐domain optical coherence tomography–a review A Hassenstein, CH Meyer Clinical & experimental ophthalmology 37 (1), 130-143, 2009	154	2009
Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab. CH Meyer, FG Holz Eye 25 (6), 661-72., 2011	151	2011
Chromovitrectomy: a new field in vitreoretinal surgery EB Rodrigues, CH Meyer, P Kroll Graefe's Archive for Clinical and Experimental Ophthalmology 243, 291-293, 2005	150	2005
Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration CH Meyer, S Mennel, JC Schmidt, P Kroll British Journal of Ophthalmology 90 (9), 1207-1208, 2006	148	2006
Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high‐resolution, spectral‐domain optical coherence tomography HM Helb, PC Issa, M Fleckenstein, S Schmitz‐Valckenberg, HPN Scholl, ... Acta ophthalmologica 88 (8), 842-849, 2010	146	2010
Intraocular pharmacokinetics after a single intravitreal injection of 1.5 mg versus 3.0 mg of bevacizumab in humans CH Meyer, TU Krohne, FG Holz Retina 31 (9), 1877-1884, 2011	138	2011
Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus A Jain, S Saxena, VK Khanna, RK Shukla, CH Meyer Molecular Vision 19, 1760-8, 2013	134	2013
Optical coherence tomography–measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections CK Chan, P Abraham, CH Meyer, GT Kokame, PK Kaiser, ME Rauser, ... Retina 30 (2), 203-211, 2010	132	2010
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study CH Meyer, HP Scholl, N Eter, HM Helb, FG Holz Acta ophthalmologica 86 (5), 490-494, 2008	130	2008
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections CH Meyer, S Michels, EB Rodrigues, A Hager, S Mennel, JC Schmidt, ... Acta ophthalmologica 89 (1), 70-75, 2011	129	2011
Vital dyes for chromovitrectomy EB Rodrigues, M Maia, CH Meyer, FM Penha, E Dib, ME Farah Current opinion in ophthalmology 18 (3), 179-187, 2007	129	2007
Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration TD Ting, M Oh, TA Cox, CH Meyer, CA Toth Archives of Ophthalmology 120 (6), 731-737, 2002	127	2002
Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection EB Rodrigues, A Grumann Jr, FM Penha, H Shiroma, E Rossi, CH Meyer, ... Journal of Ocular Pharmacology and Therapeutics 27 (2), 197-203, 2011	118	2011
Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up–The SOLO study A Bezatis, G Spital, F Höhn, M Maier, CR Clemens, J Wachtlin, ... Acta ophthalmologica 91 (5), e340-e347, 2013	114	2013
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion GB Jaissle, P Szurman, N Feltgen, B Spitzer, A Pielen, M Rehak, G Spital, ... Graefe's Archive for Clinical and Experimental Ophthalmology 249, 183-192, 2011	112	2011

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren